Abstract:Histamine injected into the hepatic artery of the dog causes dose-dependent hepatic arterial vasodilatation, whilst injections of histamine into the hepatic portal vein elicit dose-dependent portal vasoconstriction; both effects are mediated primarily through histamine H1-receptors (Richardson & Withrington, 1976, 1977). We have now examined the effects of intra-arterial and intraportal injections of histamine on the sympathetically-innervated hepatic arterial and portal venous vascular beds where both were perfused simultaneously, using a combination of techniques previously reported for the separate perfusion of the two circuits: control values were similar to those in previous publications (Richardson & Withrington, 1976, 1977). Intra-arterial injections of histamine (0.1-50 jg) elicited dose-dependent hepatic arterial vasodilatation with a maximum reduction in hepatic arterial vascular resistance (HAVR) of 44.2 + 4.3% (mean + s.e. mean; n = 8). These injections also produced dosedependent increases in hepatic portal vascular resistance (HPVR) of up to 161.6 + 54.5% on injection of histamine (50 gg) into the hepatic artery. The delay between the injection and onset of the hepatic arterial response to a selected dose (10 jg) of histamine (2.4 + 0.3 s) was significantly shorter than that to the increases in HPVR (7.7 + 1.2 s; P < 0.01). However, both hepatic vascular effects significantly preceded reductions of 5.0 + 1.2 mm Hg in systemic arterial pressure (BP) resulting from histamine entering the systemic circulation (15.6 + 1.2 s; P < 0.005). Intraportal injections of histamine (0.1-100 jg) caused dose-dependent increases in HPVR (maximum = 220.5 + 75.7%) and in addition, dose-dependent hepatic arterial vasodilatation (maximum reduction in HAVR = 37.8 + 4.1%, n = 8). On intraportal injection of histamine (10 gg), the hepatic arterial response had a significantly shorter latency than the increase in HPVR (7.2 + 0.8 s and 11.44 + 1.3 s respectively; P < 0.005), and both liver vascular effects significantly preceded the onset of reductions of 6.6 + 1.2 mm Hg in BP at 14.6 + 1.2 s (P < 0.02). The lowest doses of intraportal histamine (0.1-1.0 jg) caused negligible changes in HPVR, no systemic effects, but increases in hepatic arterial blood flow of up to 15%. The time courses of the responses to intra-arterial and intraportal histamine compared with those of the reductions in BP suggested that the effects on the two liver circuits could not be attributed to recirculation. This was further examined by injecting histamine (10 jg) into the inferior vena cava at the level of the hepatic veins: reductions of 19.5 + 4.5 mm Hg in BP occurred 4.5 + 1.0 s after injection, followed significantly later (P < 0.001) by the hepatic arterial (18.9 + 0.9 s) and portal (16.0 + 1.1 s) responses. These experiments illustrate that when histamine is released into the portal bloodstream from the gastrointestinal tract in shock or anaphylaxis (Kahlson & Rosengren, 1971), it may cause increases in hepatic arterial blood flow even though vasoactive concentrations of histamine are not attained in the systemic circulation.

Elite athletes' subjective wellbeing trajectories throughout the retirement transition: an analysis using Ruthven's (2022) transition model

The Impact of Athletic Identity, Psychological Flexibility, and Value Consistent Living on the Mental Health and Well-Being of Retired Elite Rugby Players

The effects of intra-arterial and intraportal injections of histamine on the simultaneously-perfused hepatic arterial and portal venous vascular beds of the dog [proceedings].

Retired College Student Athletes' Psychological Well-Being: A Prospective Analysis

On the Relation Between Elite Athletes' Pressure, Professional Burnout and Intention of Retirement

Natriuretic peptides and endothelin-1 in patients undergoing coronary artery bypass grafting.

Preretirement Resources and Postretirement Life Satisfaction Change Trajectory: Examining the Mediating Role of Retiree Experience During Retirement Transition Phase

Adaptation to life after sport for retired athletes: A scoping review of existing reviews and programs

End on a positive note: an exploration of flourishing, identity, and career confidence in professional Australian footballers transitioning out of football

Factorial Invariance in a Repeated Measures Design: An Application to the Study of Person-Organization Fit

A Qualitative Psychological Analysis of the Retirement Process of Athletes: Successful and Unsuccessful Case Studies

Athlete Mental Health and Wellbeing During the Transition into Elite Sport: Strategies to Prepare the System

P2PM-pay: Person to Person Mobile Payment Scheme Controlled by Expiration Date

Athletic retirement: factors contributing to sleep and mental health problems

From athletic excellence to academic influence: a study of retired Chinese athletes transitioning into the higher education sector

French fry quality related to specific gravity and solids content variation among potato strips within the same tuber

Investigation on Retirement Consciousness, Mental State and Strategy of Our Athletes

Healthy aging? An evaluation of sport participation as a resource for older adults in retirement

What Factors Determine the Success or Failure of ‘Cross-Border’ Career Development of Chinese Retired Olympic Champions? A Qualitative Comparative Analysis

A survey of elite and pre-elite athletes’ perceptions of key support, lifestyle and performance factors

Diuretic and myotropic activities of N-terminal truncated analogs of Musca domestica kinin neuropeptide